Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029641/0/en/Aphaia-Pharma-to-Participate-in-Panel-Discussion-at-SXSW-2025.html
19 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/12/19/2999869/0/en/Aphaia-Pharma-to-Participate-in-Panel-Discussion-at-the-1st-Annual-BioPharma-Obesity-Innovation-Forum-in-San-Francisco.html
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2986648/0/en/Aphaia-Pharma-to-Participate-in-a-Panel-Discussion-at-the-1st-Annual-Obesity-Metabolic-Innovation-Forum.html
09 Aug 2024
// BIOSPACE
https://www.biospace.com/drug-development/5-obesity-readouts-to-watch-in-the-second-half-of-2024
20 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/20/2901676/0/en/Aphaia-Pharma-Announces-Positive-Results-from-Phase-2-Trial-Evaluating-its-Lead-Drug-Formulation-for-Prediabetes-Treatment.html
13 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/13/2898251/0/en/Aphaia-Pharma-Completes-Enrollment-in-Arm-2-of-Phase-2-Trial-in-Individuals-with-Obesity.html
ABOUT THIS PAGE